Cellular Biomedicine Group, Inc.

CIK 1378624 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cellular Biomedicine Group, Inc..

Recent SEC filings

FiledFormAccession number
Mar 3, 202115-12G0001654954-21-002279
Feb 25, 2021EFFECT9999999995-21-000730
Feb 25, 2021EFFECT9999999995-21-000732
Feb 25, 2021EFFECT9999999995-21-000731
Feb 25, 2021EFFECT9999999995-21-000733
Feb 24, 2021SC 13D/A0001104659-21-026984
Feb 22, 2021SC 13D/A0001185185-21-000254
Feb 19, 202140001654954-21-001902
Feb 19, 202140001654954-21-001899
Feb 19, 202140001654954-21-001904
Feb 19, 202125-NSE0001354457-21-000249
Feb 19, 2021POS AM0001654954-21-001893
Feb 19, 202140001654954-21-001905
Feb 19, 2021POS AM0001654954-21-001895
Feb 19, 202140001654954-21-001906
Feb 19, 2021SC 13E3/A0001654954-21-001892
Feb 19, 2021SC 13D/A0000902664-21-001527
Feb 19, 202140001654954-21-001901
Feb 19, 2021S-8 POS0001654954-21-001897
Feb 19, 2021POS AM0001654954-21-001894
Feb 19, 20218-K0001654954-21-001890
Feb 19, 202140001654954-21-001903
Feb 19, 2021POS AM0001654954-21-001896
Feb 19, 202140001654954-21-001900
Feb 19, 202140001654954-21-001898